Mort Jane R, Aparasu Rajender R
College of Pharmacy, South Dakota State University, Rapid City, South Dakota 57701, USA.
CNS Drugs. 2002;16(2):99-109. doi: 10.2165/00023210-200216020-00003.
Psychotropic medications are an important treatment approach to mental health disorders; such disorders are common in the elderly population. Elderly patients are more likely to experience adverse effects from these agents than their younger counterparts due to age-related changes in pharmacodynamic and pharmacokinetic parameters. Because of these factors, inappropriate use of psychotropic medications in elderly patients has become a focus of concern. In general an agent is considered inappropriate if the risk associated with its use exceeds its benefit. Implicit and explicit criteria for inappropriate use of medications in the elderly have been created and include psychotropic agents. These criteria vary in their make-up but the explicit criteria tend to agree that amitriptyline, doxepin, and benzodiazepines that have long half-lives are not appropriate. Although explicit inappropriate medication criteria have been in existence since 1991, elderly patients continue to receive inappropriate psychotropic medications. A wide array of factors may be responsible for this practice. Provider-related causes include deficits in knowledge, confusion due to the lack of a consensus on the inappropriate psychotropic criteria, difficulties in addressing an inappropriate medication started by a previous provider, multiple prescribers and pharmacies involved in the care of a patient, negative perceptions regarding aging, and cost issues. Patients may contribute to the problem by demanding an inappropriate medication. Finally, the healthcare setting may inadvertently contribute to inappropriate prescribing by such policies as restrictive formularies or lack of reimbursement for pharmacists' clinical services. Successful approaches to optimising prescribing have been either educational or administrative. Educational approaches (e.g. one-on-one sessions, academic detailing) seek to influence decision making, while administrative approaches attempt to enforce policies to curtail the undesired practice. The US Omnibus Budget Reconciliation Act of 1987, which improved psychotropic medication use in long-term care, is an excellent example of administrative intervention. More research specifically focused on the causes of inappropriate psychotropic medication use and methods to avoid this practice is needed before targeted recommendations can be made.
精神药物是治疗精神健康障碍的重要方法;此类障碍在老年人群中很常见。由于药效学和药代动力学参数随年龄变化,老年患者比年轻患者更易出现这些药物的不良反应。鉴于这些因素,老年患者不适当使用精神药物已成为关注焦点。一般来说,如果某种药物使用的风险超过其益处,就被认为是不适当的。针对老年人不适当用药已制定了隐性和显性标准,其中包括精神药物。这些标准构成各异,但显性标准往往一致认为,半衰期长的阿米替林、多塞平和苯二氮䓬类药物是不合适的。尽管自1991年以来就有明确的不适当用药标准,但老年患者仍在接受不适当的精神药物治疗。这种做法可能由多种因素导致。与医疗服务提供者相关的原因包括知识欠缺、因对不适当精神药物标准缺乏共识而产生的困惑、处理前一位医疗服务提供者开始的不适当用药的困难、参与患者护理的多个开处方者和药房、对衰老的负面看法以及成本问题。患者可能因要求使用不适当药物而导致问题。最后,医疗环境可能因诸如限制性处方集或药师临床服务报销不足等政策而无意中导致不适当的处方。优化处方的成功方法要么是教育性的,要么是行政性的。教育方法(如一对一辅导、学术详述)旨在影响决策,而行政方法则试图执行政策以减少不良做法。1987年美国《综合预算协调法案》改善了长期护理中精神药物的使用,这是行政干预的一个很好例子。在能够提出有针对性的建议之前,需要更多专门针对不适当使用精神药物的原因及避免这种做法的方法的研究。